2-CdAP

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug Name2-CdAP

Drug Alias Name2-CdAP

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDNA synthesis inhibitors

TargetsNot applicable

Therapy Area/IndicationsPsoriasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGilead Sciences Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsPsoriasis

ATC CodeN/A